✦ LIBER ✦

Costs of treatment intensification for head and neck cancer: Concomitant chemoradiation randomised for radioprotection with amifostine

✍ Scribed by Marijel Braaksma; Michel van Agthoven; Wideke Nijdam; Carin Uyl-de Groot; Peter Levendag

Book ID: 116428635
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 144 KB
Volume: 41
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2005.05.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tools for optimal tissue sparing in conc

Tools for optimal tissue sparing in concomitant chemoradiation of advanced head and neck cancer: Subcutaneous amifostine and computed tomography-based target delineation

✍ Marijel Braaksma; Peter Levendag 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 276 KB

709 poster Concomitant chemoradiotherapy

709 poster Concomitant chemoradiotherapy with weekly Cisplatin and subcutaneous Amifostin in the treatment of advanced head and neck cancer

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Feasibility and toxicity of concurrent c

Feasibility and toxicity of concurrent chemoradiation for elderly patients with head and neck cancer

✍ Daly, Megan E.; Lau, Derick H.; Farwell, D. Gregory; Luu, Quang; Donald, Paul J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 294 KB

Swallowing and speech ability after trea

Swallowing and speech ability after treatment for head and neck cancer with targeted intraarterial versus intravenous chemoradiation

✍ Lisa A. Newman; K. Thomas Robbins; Jeri A. Logemann; Alfred W. Rademaker; Cathy 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 1 views

## Abstract ## Objective RADPLAT (concurrent selective supradose intraarterial cisplatin and external‐beam irradiation) delivers extraordinarily high cisplatin concentration to head and neck structures. This study was designed to quantify and compare RADPLAT and systemic chemoradiation treatment e

849 Poster Concomitant chemoradiation wi

849 Poster Concomitant chemoradiation with Docetaxel and Cisplatin for non-small-cell lung cancer and squamous cell carcinoma of head and neck

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 144 KB

O28. Randomized phase II study of concom

O28. Randomized phase II study of concomitant chemoradiation using weekly carboplatin/paclitaxel/concomitant boost radiation with or without daily subcutaneous amifostine in patients with newly diagnosed locally advanced head and neck cancer

✍ Haddad, R.; Braschayko, P.; Sonis, S.; Posner, M.; Wirth, L.; Tishler, R. 📂 Article 📅 2009 🏛 Elsevier Science ⚖ 39 KB